(Press-News.org) At this year’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, held March 7 to 11 in Las Vegas, Hospital for Special Surgery (HSS) presented new research on a variety of topics in orthopedic surgery, including studies related to minimally invasive surgery, racial disparities, and opioid alternatives for pain management in spine care.
What follows are some highlights from the meeting:
Intravenous versus Oral Administration of Acetaminophen Perioperative to Instrumented Lumbar Fusion: A Single-Center, Randomized Controlled Trial
In patients undergoing certain orthopedic surgeries, giving intravenous (IV) acetaminophen for pain relief has been shown to have fewer side effects and potentially lower risk than opioids but is associated with higher costs than oral acetaminophen. In this single-center, randomized controlled trial, investigators led by Darren R. Lebl, MD, MBA, and Celeste Abjornson, PhD, prospectively evaluated clinical outcomes of IV versus oral acetaminophen after circumferential lumbar fusion. One hundred patients between the ages of 18-85 were randomly assigned to one of the two groups (50 in each) and were included in the study. There was a specific dosing regimen that started within the three hours prior to surgery and continued for the next 48 hours. Patients were able to access supplemental opioid analgesics as needed. The researchers found that morphine consumption was significantly lower for the IV acetaminophen group compared with the oral acetaminophen group within the first 48 hours post-operatively. The average daily morphine usage after 48 hours for those who received the IV acetaminophen regimen was also significantly lower. The research suggests that IV acetaminophen is a safe and effective supplement to opioid-based pain management after surgery, and that it provides a promising option for pain control.
Authors: Gregory Paschal; Fedan Avrumova; Philip Paschal; Ellen M. Soffin, MD, PhD; Joseph Nguyen; Federico P. Girardi, MD; Andrew A. Sama, MD; Frank P. Cammisa Jr., MD; Darren R. Lebl, MD, MBA; Celeste Abjornson, PhD, (HSS)
*
Racial Disparities in Outpatient Anterior Cervical Discectomy and Fusion and Cervical Disc Replacement
Recent reports have suggested disparities within cervical spine surgery, including lower utilization rates and worse perioperative outcomes for Black patients. In this retrospective cohort study, a team led by HSS resident Troy B. Amen sought to assess whether these disparities also exist for outpatient cervical spine surgery. Using data collected by the American College of Surgeons National Surgical Quality Improvement Program between 2010 and 2019, the team looked at patients who underwent primary anterior cervical discectomy and fusion (ACDF) or cervical disc replacement (CDR) and stratified them by race and ethnicity. They categorized procedures as inpatient or outpatient based on length of stay. They found that, overall, Black patients were significantly less likely to undergo ACDF (5.9%, vs. 10.6% of white patients) as well as CDR (19.9%, vs. 26.1% of white patients) as outpatients. Between 2010 and 2019, these disparities increased, even when adjusting for other factors. The findings highlight the need for renewed intervention by orthopedic surgeons and policymakers to address inequalities in outpatient care.
Authors: Troy B. Amen; Patawut Bovonratwet, (HSS); Samuel S. Rudisill (Rush Medical College); Lauren Barber; Yusef Jordan, (HSS); Abhinaba Chatterjee (Weill Cornell Medicine); Jung Kee Mok (UNC Chapel Hill); Nathan Varady; Sheeraz Qureshi, MD, MBA (HSS)
*
Improving Racial and Ethnic Disparities in Ambulatory Surgical Center Utilization for Anterior Cervical Discectomy and Fusion
Although racial and ethnic disparities within the field of spine surgery have been documented, the link between the recent emergence of ambulatory surgical centers and access to these procedures in the outpatient setting isn’t known. A study led by HSS resident Troy B. Amen sought to assess disparities in the use of these outpatient surgical centers among white, Black, and Hispanic patients having spine surgery. The investigators also looked at how racial differences have changed between 2015 and 2018. Using data from the Healthcare Cost and Utilization Project New York State Ambulatory Database, the researchers looked at differences in same-day discharges in patients having anterior cervical discectomy and fusion (ACDF). They found that during this time, Black and Hispanic patients were significantly less likely to undergo ACDF surgery at an ambulatory center compared with white patients, but that these disparities lessened over time. They note that these improvements are encouraging and may help counteract previously documented disparities in spine surgery in the inpatient setting, although additional research is needed to confirm that.
Authors: Troy B. Amen, (HSS); Abhinaba Chatterjee (Weill Cornell Medicine); Sheeraz Qureshi, MD, MBA (HSS)
Predictors of Non-improvement After Minimally Invasive Lumbar Spine Surgery
Minimally invasive surgery of the lumbar spine is associated with good clinical outcomes, but a small number of patients may not improve, or may even worsen, after this surgery. A study led by HSS research fellow Junho Song sought to identify predictors of patients who are not likely to improve. The study included 448 patients who underwent minimally invasive transforaminal interbody fusion, laminectomy, or microdiscectomy at HSS between 2017 and 2021. At follow-up of at least six months after surgery, the patients were categorized as better, the same, or worse. A total of 66 patients reported no significant improvement; among these, 35 patients reported worsening after surgery, and the rest reported no change. Patients who did not fare as well were more likely to be older or obese. The researchers found that smoking was also a factor for those who didn’t do as well, likely due to changes in metabolic systems and local vasculature caused by tobacco use. The investigators say these findings provide valuable evidence that may be useful for improving the selection of patients to undergo minimally invasive spine surgery. They may also help to establish clearer patient expectations for those undergoing this procedure.
Authors: Junho Song; Pratyush Shahi; Kasra Araghi; Robert Kamil; Dimitra Melissaridou; Sidhant Singh Dalal (University of Arkansas for Medical Sciences); Daniel Shinn; Sheeraz Qureshi, MD, MBA; Sravisht Iyer, MD (HSS)
*
Robotics Reduces Radiation Exposure in Minimally Invasive Lumbar Fusion Compared to Navigation
For minimally invasive spine surgery, navigation and robotics technologies have helped reduce surgeons’ exposure to ionizing radiation. Studies have compared radiation exposure during surgery using robotics or navigation to procedures using traditional fluoroscopy, but none have compared robotics and navigation to each other. This study compared the two techniques in terms of fluoroscopy time and radiation dose for minimally invasive transforaminal lumbar interbody fusion (MI-TLIF). The study included 111 patients in the robotics cohort and 133 patients in the navigation cohort. The investigators, led by HSS research fellow Pratyush Shahi, found that for both one- and two-level TLIFs, the fluoroscopy time for surgical procedure, total fluoroscopy time, and total radiation dose were significantly less with robotics compared to navigation. For one-level TLIFs, the overall time of radiation exposure was also lower. Overall, time in the operating room was similar, with robotic procedures lasting longer but requiring less time for setup and image capture. Based on these findings, the investigators say robotic surgery leads to a significant reduction in radiation exposure both for the surgeon and the patient compared to navigation, but multicenter prospective trials are needed to confirm these findings.
Authors: Pratyush Shahi, Sidhant Singh Dalal (University of Arkansas for Medical Sciences); Junho Song; Daniel Shinn; Robert Kamil; Kasra Araghi; Sheeraz Qureshi, MD, MBA (HSS)
END
HSS presents research at 2023 AAOS Annual Meeting
2023-03-09
ELSE PRESS RELEASES FROM THIS DATE:
CityU researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target
2023-03-09
Cancer metastasis is a major cause of cancer-related death. A research team at City University of Hong Kong (CityU) recently identified a protein that triggers the migration of liver and pancreatic cancer cells and metastasis, and is correlated with shortening the survival time of patients. The research findings were verified by in vitro and in vivo models, supported with clinical data, and are expected to provide a new potential target for cancer therapy.
“Cancer metastasis is a complex process. Stiffness in tumours and the surrounding tissues is known to increase along with the tumour growth, which creates confined spaces or channel-like tracks of pores for tumour ...
An on-chip viscoelasticity sensor for biological fluids
2023-03-09
A research paper by scientists at the Hebei University of Technology and Shenzhen University developed an on-chip viscoelasticity sensor for biological fluids.
The new research paper, published on Jan. 10, 2023 in the journal Cyborg and Bionic Systems, reported a double-layered microfluidic sensor to detect the ultra-weak viscoelasticity in biological fluids.
“Most of human body fluids are non-Newtonian liquids, and the influence of viscoelasticity is often ignored for the sake of simplification of analysis. However, we ...
An overview of in vitro biological neural networks for robot intelligence
2023-03-09
A review paper by scientists at the Beijing Institute of Technology summarized recent efforts and future potentials in the use of in vitro biological neural networks (BNNs) for the realization of biological intelligence, with a focus on those related to robot intelligence.
The review paper, published on Jan. 10 in the journal Cyborg and Bionic Systems, provided an overview of 1) the underpinnings of intelligence presented in in vitro BNNs, such as memory and learning; 2) how these BNNs can be embodied with robots through bidirectional ...
ASBMB announces 2023 class of fellows
2023-03-09
The American Society for Biochemistry and Molecular Biology today announced its 2023 class of fellows. The honorific program recognizes scientists who have made outstanding contributions to the field through their research, teaching, mentoring or other forms of service.
The society will recognize the 20 new fellows at its annual meeting, Discover BMB, later this month in Seattle. The presentation will be part of the society's presidential address and business meeting scheduled for Saturday, March 25.
“This group truly represents members who have ...
Novel rare skin mutation gene identified by whole exome sequencing - BGI Case Report
2023-03-09
Harlequin ichthyosis (HI) is a severe genetic skin disorder characterized by thick white, brown, or dark brown patches on the skin covering a newborn's entire body. HI has a low incidence of 1 per 300,000 live births but comes with the highest mortality rate among skin conditions. It is caused by a mutation in the ABCA12 gene, which codes for a protein involved in transporting lipids necessary for the formation of the skin barrier. Such protein shortage leads to a weaker epidermal barrier.
A recent study, co-authored by BGI Genomics Dr. Thomas Qiu, published in Frontiers in Pediatrics covers ...
Like a flexible Lego railway track: How stable microtubules form within cells
2023-03-09
Like poles support a tent, microtubules—hollow cylindrical structures made of tubulin protein—support eukaryotic cells. But microtubules provide more than just mechanical strength; they help prepare the cell for cell division and migration and work as a railway track on which motor proteins transport materials within the cell. The formation of microtubules within cells resembles how a child assembles a Lego train track. The tubulins—Lego bricks—constantly assemble and disassemble to make the microtubule—train track—longer and shorter in processes called polymerization and depolymerization. The processes are regulated by microtubule-associated proteins such ...
What if California didn’t close down during the pandemic?
2023-03-09
SAN FRANCISCO (March 9, 2023) — Researchers at the California Academy of Sciences, along with a collaborator at Denison University, have developed an innovative new model to assess how the California economy might have fared without economic closures to slow the spread of the coronavirus pandemic. Their initial findings—published today in Frontiers in Physics—reveal that under a “business-as-usual” approach wherein there were no business closures, California’s economy would have generally been better off than in reality. However, the economic impacts would still have been substantial and ...
Americans share fake news to fit in with social circles
2023-03-09
Both conservative and liberal Americans share fake news because they don’t want to be ostracized from their social circles, according to research published by the American Psychological Association.
“Conformity and social pressure are key motivators of the spread of fake news,” said lead researcher Matthew Asher Lawson, PhD, an assistant professor of decision sciences at INSEAD, a business school in France. “If someone in your online tribe is sharing fake news, then you feel pressure to share it as well, even if you don’t ...
A safe synthesis of hydrogen peroxide inspired by nature
2023-03-09
Fukuoka, Japan—Hydrogen peroxide is a ubiquitous chemical found in most homes and used in everything from dying hair to treating wounds. It is also an invaluable agent for many industries from food, textiles, and even in semiconductor production.
Reporting in JACS, researchers at Kyushu University have developed a new process to synthesize this chemical utilizing a new homogeneous catalyst inspired by nature. Moreover, the process is significantly safer than conventional methods.
Scientists have been reporting the synthesis ...
A novel mechanism may be effective in patients with severe hypertriglyceridemia and prior episodes of acute pancreatitis
2023-03-09
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG is a well-established risk factor for recurrent episodes of acute pancreatitis. These high-risk patients were the focus of a phase 2 study that was led by the Icahn School of Medicine at Mount Sinai and sponsored and funded by Regeneron.
This ANGPTL3 inhibitor therapy, the intravenous drug evicanumab-dgnb, inhibits two important regulators of lipoprotein metabolism. ...